- NPMI

Muscat Securities Market (Sultanat of Oman)
0.12 Last Update 22/07/2018 12:45 KSA
× lblWarning! {{companyMessage}}
  • :0.12
  • :0.12
  • ('000):50,000
  • (OMR '000):5,800
  • :-0.03


  • 0
  • :02
  • :0
  • 52-W L52-W H
    0.12
    0.00000.12
  • 3.33%
  • -


  • 0

  • (OMR):

    0
  • (OMR):00
  • :0
  • Performance Comparison

Activities

National Pharmaceutical Industries Company (NPMI) is a public company, based in Muscat (Oman), and established in February 1996. NPMI is a subsidiary of Oman Investment Fund Holding Co. and is listed on the Muscat Securities Market since January 2005. The company specializes in the production of anti-allergic, anti-inflammatory, antidepressant,and anti-diabetic medications, and also gastrointestinal drugs. It is among the first pharmaceutical formulations manufacturing plant in Sultanate of Oman. It offers lipid lowering, cardio vascular, anti-bacterial, anti-allergic, non-steroidal anti-inflammatory, gastro intestinal, anti-diabetic, anti-depressant, and analgesic anti-pyretic products too. The company also operates worldwide in almost 12 countries and has a business base in the Gulf and Middle East counties for almost a decade. The company's facilities are spread over a 30,042.43 square meters plot of land, and includes a non-beta lactum plant for producing oral solids, liquids, drops, dry suspensions and sachets; a beta lactum plant, which engages in production of capsules and dry suspension; a research and development laboratory, and a quality control laboratory.

  • Chairman:
    Ghazi O. Al Zubeidi
  • Vice-chairman:
    Abdullah M. B. Al Qenaei
  • CEO:
    G . Sridhar
  • Board Members:

    Amal S. Bahwan

    Khalifa S. Al Mohannadi

    Mahmoud A. Zubaid

    Omar S. Bahwan

  • Auditors:

    Moore Stephens

CMA clears OMR5m rights issue of National Pharmaceuticals (Times of Oman - 24/12/2017)

National Pharmaceutical Industries Company plans to raise its capital by OMR5 million by way of a ...

Read More ...

Read More ...
Announced On Period As Of Net Profit (SAR Mil) Growth (%)
12/04/2018 3-Month 31/03/2018 00 16.39
14/01/2018 12-Month 31/12/2017 02 21.33
12/10/2017 9-Month 30/09/2017 01 7.05
12/07/2017 6-Month 30/06/2017 01 -9.96
12/04/2017 3-Month 31/03/2017 00 5.06
Market Cap
US$ Mil
Last Price
Local Cry
Price Change (%)
1 Day
Price Change (%)
1 Year
P/E TTM P/B MRQ Dividend Yield (%) Beta ROA (%) ROE (%)
MOUASAT 2,535.18 95.3 -0.73 30.1 26.62 3.42 1.58 0.74 13.85 22.49
MEAHCO 1,517.18 62.4 1.46 -20.85 20.55 3.49 3.23 0.78 11.92 18.76
DALLAHHEALTH 1,456.47 92 -0.65 -16.27 20.41 3.37 2.7 0.9 12.1 17.53
SPIMACO 1,032.18 32.3 0 -7.1 25.6 1.47 3.1 0.84 8.47 15.11
CARE 680.78 57.7 1.94 26.96 26.81 2.65 1.75 0.9 -0.59 -0.89
JULPHAR 658.27 2.15 0 -10.04 34.68 1.04 5.27 0.22 4.09 0
ATC.KSE 544.01 1,100 0 0 18.48 3.34 1.82 -0.01 2.93 12.88
MCGS 540.98 68.5 -2.15 -15.05 23.86 1.97 5.93 0.96 6.76 7.99
GMPC 338.64 1.78 0 -56.69 40.36 0.95 3 -0.08 75.81 111.42
YIACO 77.97 130 0 -24.42 -2.49 2.42 0 0.2 -8.47 -63.6
QGMD 16.43 5.23 0.96 -36.67 -2.76 0.86 0 0.88 -6.18 0
NPMI 15.04 0.12 0 2.65 3.49 0.73 11.67 -0.03 6.11 0